Palisade Bio announces closing of $13.8M upsized underwritten public offering
A biopharma company advancing therapies for acute and chronic gastrointestinal (GI) complications has announced today…
August 17, 2022 - 2 minutes
A biopharma company advancing therapies for acute and chronic gastrointestinal (GI) complications has announced today…